parecoxib has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, M; Dines-Muntaner, S; Fullerton, S; Thakerar, A; Trifunovich, T | 1 |
| Chen, Z; Li, L; Li, S; Yang, Y; Zhang, L | 1 |
| Cheng, C; Jia, Y; Jin, X; Liu, Y; Wang, G; Yao, L; Zhang, J; Zhou, F | 1 |
3 other study(ies) available for parecoxib and Neoplasms
| Article | Year |
|---|---|
Parecoxib as an adjunct therapy for the treatment of refractory non-surgical cancer pain.
Topics: Adult; Aged; Aged, 80 and over; Australia; Cancer Pain; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Neoplasms; Pain Measurement; Retrospective Studies; Young Adult | 2020 |
COX‑2 inhibition in the endothelium induces glucose metabolism normalization and impairs tumor progression.
Topics: Animals; Antineoplastic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Progression; Endothelial Cells; Female; Glucose; Glycolysis; Isoxazoles; Mice, Inbred C57BL; Neoplasms; Ovarian Neoplasms; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2018 |
Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice.
Topics: Animals; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 Enzyme System; Drug Monitoring; Female; Humans; Isoxazoles; Mice; Mice, Inbred BALB C; Neoplasms; Oxazoles; Prodrugs; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Tandem Mass Spectrometry; Xenograft Model Antitumor Assays | 2018 |